Human immunodeficiency virus type 1 reverse transcription is stimulated by Tat from other lentiviruses

Virology

Volumn 300, Issue 2, 2002, Pages 226-235

  Hooker, C William ^a,b   Scott, Julie ^a   Apolloni, Ann ^a,b   Parry, Emma ^a,b   Harrich, David ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Equine infectious anemia virus; Human immunodeficiency virus; Jembrana disease virus; Reverse transcription; tat; Transcription

Indexed keywords

TRANSACTIVATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; EQUINE INFECTIOUS ANEMIA VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION;

EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; JEMBRANA DISEASE VIRUS;

EID: 0036392213     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1554     Document Type: Article

References (29)

1. Aiken, C., and Trono, D. (1995). Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69(8), 5048-5056.
2. Allain, B., Lapadat-Tapolsky, M., Berlioz, C., and Darlix, J. L. (1994). Transactivation of the minus-strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome. EMBO J. 13(4), 973-981.
3. Arya, S. K., Beaver, B., Jagodzinski, L., Ensoli, B., Kanki, P. J., Albert, J., Fenyo, E. M., Biberfeld, G., Zagury, J. F., Laure, F., et al. (1987). New human and simian HIV-related retroviruses possess functional trans-activator (tat) gene. Nature 328(6130), 548-550.
4. Baltimore, D. (1970). RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 226(252), 1209-1211.
5. Carroll, R., Martarano, L., and Derse, D. (1991). Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras. J. Virol. 65(7), 3460-3467.
6. Chen, H., He, J., Fong, S., Wilcox, G., and Wood, C. (2000). Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication. J. Virol. 74(6), 2703-2713.
7. Dettenhofer, M., Cen, S., Carlson, B. A., Kleiman, L., and Yu, X. F. (2000). Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription. J. Virol. 74(19), 8938-8945.
8. Harrich, D., Hooker, C. W., and Parry, E. (2000). The human immunodeficiency virus type 1 TAR RNA upper stem-loop plays distinct roles in reverse transcription and RNA packaging. J. Virol. 74(12), 5639-5646.
9. Harrich, D., Ulich, C., Garcia-Martinez, L. F., and Gaynor, R. B. (1997). Tat is required for efficient HIV-1 reverse transcription. EMBO J. 16(6), 1224-1235.
10. Hooker, C. W., Lott, W. B., and Harrich, D. (2001). Inhibitors of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse transcription. J. Virol. 75(7), 3095-3104.
11. Huang, L. M., Joshi, A., Willey, R., Orenstein, J., and Jeang, K. T. (1994). Human immunodeficiency viruses regulated by alternative trans-activators: Genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J. 13(12), 2886-2896.
12. Huang, Y., Khorchid, A., Gabor, J., Wang, J., Li, X., Darlix, J. L., Wainberg, M. A., and Kleiman, L. (1998). The role of nucleocapsid and U5 stem/A-rich loop sequences in tRNA(3Lys) genomic placement and initiation of reverse transcription in human immunodeficiency virus type 1. J. Virol. 72(5), 3907-3915.
13. Isel, C., Westhof, E., Massire, C., Le Grice, S. F., Ehresmann, B., Ehresmann, C., and Marquet, R. (1999). Structural basis for the specificity of the initiation of HIV-1 reverse transcription. EMBO J. 18(4), 1038-1048.
14. Jones, K. A. (1997). Taking a new TAK on tat transactivation. Genes Dev. 11(20), 2593-2599.
15. Kameoka, M., Rong, L., Gotte, M., Liang, C., Russell, R. S., and Wainberg, M. A. (2001). Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication. J. Virol. 75(6), 2675-2683.
16. Ohagen, A., and Gabuzda, D. (2000). Role of Vif in stability of the human immunodeficiency virus type 1 core. J. Virol. 74(23), 11055-11066.
17. Rabson, A. B., and Graves, B. J. (1997). Synthesis and processing of viral RNA. In "Retroviruses" (J. M. Coffin, S. H. Hughes, and H. E. Varmus, Eds.), pp. 205-262. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
18. Schwartz, O., Marechal, V., Danos, O., and Heard, J. M. (1995). Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69(7), 4053-4059.
19. Smith, C. A., Calabro, V., and Frankel, A. D. (2000). An RNA-binding chameleon. Mol. Cell 6(5), 1067-1076.
20. Stauber, R. H., and Pavlakis, G. N. (1998). Intracellular trafficking and interactions of the HIV-1 Tat protein. Virology 252(1), 126-136.
21. Sune, C., Goldstrohm, A. C., Peng, J., Price, D. H., and Garcia-Blanco, M. A. (2000). An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation. Virology 274(2), 356-366.
22. Taube, R., Fujinaga, K., Wimmer, J., Barboric, M., and Peterlin, B. M. (1999). Tat transactivation: A model for the regulation of eukaryotic transcriptional elongation. Virology 264(2), 245-253.
23. Taylor, J. M. (1977). An analysis of the role of tRNA species as primers for the transcription into DNA of RNA tumor virus genomes. Biochim. Biophys. Acta 473(1), 57-71.
24. Temin, H. M., and Mizutani, S. (1970). RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 226(252), 1211-1213.
25. Ulich, C., Dunne, A., Parry, E., Hooker, C. W., Gaynor, R. B., and Harrich, D. (1999). Functional domains of Tat required for efficient human immunodeficiency virus type 1 reverse transcription. J. Virol. 73(3), 2499-2508.
26. Verhoef, K., Koper, M., and Berkhout, B. (1997). Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication. Virology 237(2), 228-236.
27. You, J. C., and McHenry, C. S. (1994). Human immunodeficiency virus nucleocapsid protein accelerates strand transfer of the terminally redundant sequences involved in reverse transcription. J. Biol. Chem. 269(50), 31491-31495.
28. Zhang, H., Dornadula, G., and Pomerantz, R. J. (1998). Natural endogenous reverse transcription of HIV type 1. AIDS Res. Hum. Retroviruses 14(Suppl. 1), S93-S95.
29. Zhang, H., Pomerantz, R. J., Dornadula, G., and Sun, Y. (2000). Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process. J. Virol. 74(18), 8252-8261.